Literature DB >> 28409725

Genetic landscape of sporadic vestibular schwannoma.

Aril Løge Håvik1,2,3, Ove Bruland2, Erling Myrseth4, Hrvoje Miletic5,6,7, Mads Aarhus8, Per-Morten Knappskog2,3, Morten Lund-Johansen1,4,6.   

Abstract

OBJECTIVE Vestibular schwannoma (VS) is a benign tumor with associated morbidities and reduced quality of life. Except for mutations in NF2, the genetic landscape of VS remains to be elucidated. Little is known about the effect of Gamma Knife radiosurgery (GKRS) on the VS genome. The aim of this study was to characterize mutations occurring in this tumor to identify new genes and signaling pathways important for the development of VS. In addition, the authors sought to evaluate whether GKRS resulted in an increase in the number of mutations. METHODS Forty-six sporadic VSs, including 8 GKRS-treated tumors and corresponding blood samples, were subjected to whole-exome sequencing and tumor-specific DNA variants were called. Pathway analysis was performed using the Ingenuity Pathway Analysis software. In addition, multiplex ligation-dependent probe amplification was performed to characterize copy number variations in the NF2 gene, and microsatellite instability testing was done to investigate for DNA replication error. RESULTS With the exception of a single sample with an aggressive phenotype that harbored a large number of mutations, most samples showed a relatively low number of mutations. A median of 14 tumor-specific mutations in each sample were identified. The GKRS-treated tumors harbored no more mutations than the rest of the group. A clustering of mutations in the cancer-related axonal guidance pathway was identified (25 patients), as well as mutations in the CDC27 (5 patients) and USP8 (3 patients) genes. Thirty-five tumors harbored mutations in NF2 and 16 tumors had 2 mutational hits. The samples without detectable NF2 mutations harbored mutations in genes that could be linked to NF2 or to NF2-related functions. None of the tumors showed microsatellite instability. CONCLUSIONS The genetic landscape of VS seems to be quite heterogeneous; however, most samples had mutations in NF2 or in genes that could be linked to NF2. The results of this study do not link GKRS to an increased number of mutations.

Entities:  

Keywords:  CDC27; GKRS = Gamma Knife radiosurgery; IPA = Ingenuity Pathway Analysis; LOH = loss of heterozygosity; MLPA = multiplex ligation-dependent probe amplification; MSI = microsatellite instability; NF2; PCR = polymerase chain reaction; SNV = single-nucleotide variant; USP8; VS = vestibular schwannoma; WES = whole-exome sequencing; axonal guidance; molecular biology; next-generation sequencing; sVS = sporadic VS; vestibular schwannoma

Mesh:

Year:  2017        PMID: 28409725     DOI: 10.3171/2016.10.JNS161384

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  23 in total

Review 1.  The 100 most-cited articles on vestibular schwannoma: historical perspectives, current limitations, and future research directions.

Authors:  Rafael Martinez-Perez; Timothy H Ung; A Samy Youssef
Journal:  Neurosurg Rev       Date:  2021-02-01       Impact factor: 3.042

2.  Proposal for Modification of Cahan's Criteria Utilizing Molecular Genetic Analyses for Cases without Baseline Histopathology: A Unique Method Applicable to Primary Radiosurgery.

Authors:  Aaron E Rusheen; James B Smadbeck; Lisa A Schimmenti; Eric W Klee; Michael J Link; George Vasmatzis; Matthew L Carlson
Journal:  J Neurol Surg B Skull Base       Date:  2018-05-31

3.  Main Symptom that Led to Medical Evaluation and Diagnosis of Vestibular Schwannoma and Patient-Reported Tumor Size: Cross-sectional Study in 1,304 Patients.

Authors:  Maria Peris-Celda; Christopher S Graffeo; Avital Perry; Panagiotis Kerezoudis; Nicole M Tombers; Matthew L Carlson; Michael J Link
Journal:  J Neurol Surg B Skull Base       Date:  2018-10-09

4.  Dramatic Growth of a Vestibular Schwannoma After 16 Years of Postradiosurgery Stability in Association With Exposure to Tyrosine Kinase Inhibitors.

Authors:  Lucas P Carlstrom; Amanda Muñoz-Casabella; Avital Perry; Christopher S Graffeo; Michael J Link
Journal:  Otol Neurotol       Date:  2021-12-01       Impact factor: 2.619

Review 5.  Genetic Events and Signaling Mechanisms Underlying Schwann Cell Fate in Development and Cancer.

Authors:  Harish N Vasudevan; Calixto-Hope G Lucas; Javier E Villanueva-Meyer; Philip V Theodosopoulos; David R Raleigh
Journal:  Neurosurgery       Date:  2021-01-13       Impact factor: 4.654

Review 6.  Genetic contribution to vestibular diseases.

Authors:  Alvaro Gallego-Martinez; Juan Manuel Espinosa-Sanchez; Jose Antonio Lopez-Escamez
Journal:  J Neurol       Date:  2018-03-26       Impact factor: 4.849

7.  EANO guideline on the diagnosis and treatment of vestibular schwannoma.

Authors:  Roland Goldbrunner; Michael Weller; Jean Regis; Morten Lund-Johansen; Pantelis Stavrinou; David Reuss; D Gareth Evans; Florence Lefranc; Kita Sallabanda; Andrea Falini; Patrick Axon; Olivier Sterkers; Laura Fariselli; Wolfgang Wick; Joerg-Christian Tonn
Journal:  Neuro Oncol       Date:  2020-01-11       Impact factor: 12.300

8.  Commentary: Genetic Events and Signaling Mechanisms Underlying Schwann Cell Fate in Development and Cancer.

Authors:  Aria M Jamshidi; Anthony Diaz; S Shelby Burks; Allan D Levi
Journal:  Neurosurgery       Date:  2021-01-13       Impact factor: 4.654

9.  Clinical features and outcomes of adrenal schwannoma: a study of 13 cases from a single centre.

Authors:  Henghai Huang; Qijian Ding; Xiaocao Lin; Delin Li; Jingjing Zeng; Weijin Fu
Journal:  Endocr Connect       Date:  2021-05-19       Impact factor: 3.335

Review 10.  Genomics, Epigenetics, and Hearing Loss in Neurofibromatosis Type 2.

Authors:  Christine T Dinh; Eric Nisenbaum; Darius Chyou; Carly Misztal; Denise Yan; Rahul Mittal; Juan Young; Mustafa Tekin; Fred Telischi; Cristina Fernandez-Valle; Xue-Zhong Liu
Journal:  Otol Neurotol       Date:  2020-06       Impact factor: 2.619

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.